GK
George William Kasule

Publications (13)

Association of Human Cytomegalovirus exposure with tuberculosis disease in South African adults with presumptive tuberculosis
Article scientifique · 2026
Patterns of compensatory mutations in rpoA/B/C genes of multidrug resistant M. tuberculosis in Uganda
Article scientifique · 2025
Patterns of compensatory mutations in rpoA/B/C genes of multidrug resistant M. tuberculosis in Uganda
Article scientifique · 2025
Diagnostic accuracy of Truenat® MPX assay in comparison to Non-variola Orthopoxvirus RT PCR for diagnosis of mpox disease in Uganda
Article scientifique · 2026
The development and implementation of a proficiency testing program for SARS-CoV-2 using dried tube specimens in resource-limited countries
Article scientifique · 2024
A stool based qPCR for the diagnosis of TB in children and people living with HIV in Uganda, Eswatini and Mozambique (Stool4TB): a protocol for a multicenter diagnostic evaluation
Article scientifique · 2024
Evaluation of Xpert MTB/XDR test for susceptibility testing of Mycobacterium tuberculosis to first and second-line drugs in Uganda
Article scientifique · 2023
Advancing proficiency testing for ultra in resource-limited settings using dried tube specimen: A study by SRL-Uganda
Article scientifique · 2023
Phylogenetic lineages of tuberculosis isolates and their association with patient demographics in Tanzania
Article scientifique · 2022
First report of whole-genome analysis of an extensively drug-resistant Mycobacterium tuberculosis clinical isolate with bedaquiline, linezolid and clofazimine resistance from Uganda
Article scientifique · 2022
Implementation of GeneXpert MTB/Rif proficiency testing program: A Case of the Uganda national tuberculosis reference laboratory/supranational reference laboratory
Article scientifique · 2021
Frequency and patterns of second-line resistance conferring mutations among MDR-TB isolates resistant to a second-line drug from eSwatini, Somalia and Uganda (2014–2016)
Article scientifique · 2019
Mycobacterium tuberculosis Uganda II is more susceptible to rifampicin and isoniazid compared to Beijing and Delhi/CAS families
Article scientifique · 2016

Domaines principaux

Sciences de la santé13

Statistiques

Consultations23
Téléchargements0